Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 242

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 19
Chunk 242
---
52,093      ¥          46,549  
  Finance Expenses:                                                                                                                                                                                       
  Interest expense                                                                                                                                                                                        
  Interest expense on financial debt                                                                              ¥                                100,393      ¥          98,710      ¥         112,800  
  Interest expense on lease liabilities                                                                                                             16,580                 20,826                 24,511  
  Total interest expense                                                                                                                           116,973                119,535                137,311  
  Loss on derivatives – Virtual power purchase agreement                                                                                             6,843                  3,393                  5,311  
  Loss on foreign currency exchange, net                                                                                                            14,205                 44,665                  7,213  
  Hyperinflation effect expense                                                                                                                     12,256                 18,160                 10,565  
  Other                                                                                                                                             19,421                 34,096                 49,665  
  Total                                                                                                           ¥                                169,698      ¥         219,850      ¥         210,065  

For the year ended March 31, 2025, ” Other” in finance expenses includes JPY 18,885

F-29

7. Income Taxes

Income Tax Expense (Benefit)

The composition of income tax expense (benefit) is as follows:

                            JPY (millions)                                                                                  
                            For the Year Ended March 31                                                                     
                            2023                                             2024                      2025                 
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Current tax expense       ¥                                   246,578      ¥            107,349      ¥           138,057  
  Deferred tax benefit                                       ( 188,526)                ( 198,755)                ( 71,116)  
  Total                     ¥                                    58,052      ¥          ( 91,406)      ¥            66,941  

Current tax expense includes the benefits arising from previously unrecognized tax losses, tax credits and temporary differences of prior periods. These effects decreased current tax expense by JPY 17,529 4,952 4,654 317

Deferred tax benefit includes the benefits arising from previously unrecognized tax losses, tax credits and temporary differences of prior periods. These effects increased deferred tax benefits by JPY 54,974 32,290 19,542

Takeda is mainly subject to income taxes, inhabitant tax, and deductible enterprise tax in Japan. The